Loomis, Sayles & Company’s Illumina ILMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$363M Sell
2,942,977
-1,228,743
-29% -$161M 0.49% 32
2025
Q4
$547M Sell
4,171,720
-115,708
-3% -$13.6M 0.66% 29
2025
Q3
$407M Buy
4,287,428
+61,899
+1% +$6.14M 0.48% 34
2025
Q2
$403M Buy
4,225,529
+78,317
+2% +$6.36M 0.51% 34
2025
Q1
$329M Sell
4,147,212
-62,948
-1% -$6.81M 0.48% 37
2024
Q4
$563M Sell
4,210,160
-132,580
-3% -$18.9M 0.71% 28
2024
Q3
$566M Sell
4,342,740
-119,254
-3% -$14.7M 0.74% 29
2024
Q2
$466M Sell
4,461,994
-73,827
-2% -$8.28M 0.64% 31
2024
Q1
$606M Sell
4,535,821
-12,758
-0.3% -$1.71M 0.86% 29
2023
Q4
$616M Buy
4,548,579
+428,399
+10% +$49.4M 0.94% 26
2023
Q3
$550M Buy
4,120,180
+214,099
+5% +$35.2M 0.95% 26
2023
Q2
$712M Buy
3,906,081
+398,790
+11% +$80.7M 1.15% 23
2023
Q1
$793M Buy
3,507,291
+190,146
+6% +$38.9M 1.38% 20
2022
Q4
$652M Sell
3,317,145
-381,897
-10% -$79.1M 1.31% 24
2022
Q3
$687M Sell
3,699,042
-137,555
-4% -$27.2M 1.39% 22
2022
Q2
$688M Buy
3,836,597
+196,699
+5% +$50.2M 1.28% 24
2022
Q1
$1.24B Sell
3,639,898
-65,640
-2% -$22.2M 1.65% 20
2021
Q4
$1.37B Buy
3,705,538
+417,554
+13% +$158M 1.66% 20
2021
Q3
$1.3B Sell
3,287,984
-18,280
-0.6% -$8.41M 1.6% 19
2021
Q2
$1.52B Sell
3,306,264
-149,223
-4% -$60.1M 1.84% 19
2021
Q1
$1.29B Sell
3,455,487
-144,645
-4% -$59M 1.67% 21
2020
Q4
$1.3B Sell
3,600,132
-569
-0% -$181K 1.71% 21
2020
Q3
$1.08B Buy
3,600,701
+1,318,833
+58% +$454M 1.58% 18
2020
Q2
$822M Buy
2,281,868
+1,076,894
+89% +$347M 1.32% 25
2020
Q1
$320M Buy
+1,204,974
New +$337M 0.66% 36
2017
Q3
Sell
-30
Closed -$5K 948
2017
Q2
$5K Buy
+30
New +$5.19K ﹤0.01% 864

Other funds holding ILMN

Loomis, Sayles & Company's ILMN Position: Q1 2026 in Review

Loomis, Sayles & Company reduced its Illumina (ILMN) stake by 29% in Q1 2026, selling an estimated $161M and leaving 2,942,977 shares worth $363M. The position accounts for 0.49% of the portfolio, ranked #32.

Loomis, Sayles & Company first reported a position in ILMN in Q2 2017 and has held it in 26 quarters since. The position peaked at $1.52B in Q2 2021. 845 funds tracked by Wall St. Rank hold ILMN as of Q1 2026.

  • Loomis, Sayles & Company held 2,942,977 shares of Illumina worth $363M as of Q1 2026.
  • Loomis, Sayles & Company sold 1,228,743 Illumina shares in Q1 2026, an estimated $161M.
  • Illumina made up 0.49% of Loomis, Sayles & Company's portfolio in Q1 2026, its #32 holding.
  • Loomis, Sayles & Company first reported a position in Illumina in Q2 2017 and has held it in 26 quarters since.
  • Loomis, Sayles & Company's Illumina position peaked at $1.52B in Q2 2021.
  • 845 funds tracked by Wall St. Rank held Illumina as of Q1 2026.

Based on Loomis, Sayles & Company's 13F filing for Q1 2026, filed 14 May 2026.